Resverlogix Corp. (RVX) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.011x

Based on the latest financial reports, Resverlogix Corp. (RVX) has a cash flow conversion efficiency ratio of 0.011x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-972.79K ≈ $-703.70K USD) by net assets (CA$-90.31 Million ≈ $-65.33 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Resverlogix Corp. (RVX) defensive interval to measure how many days the company can operate on defensive assets alone.

Resverlogix Corp. - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Resverlogix Corp.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Resverlogix Corp. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Resverlogix Corp. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Seker Finansal Kiralama AS
IS:SEKFK
0.184x
Picogram Co. Ltd.
KQ:376180
-0.003x
Hamama
TA:HMAM
0.187x
First Hydrogen Corp
V:FHYD
0.032x
Games Operators SA
WAR:GOP
0.024x
ESS Tech Inc
NYSE:GWH
-1.425x
Wing Yip Food Holdings Group Limited American Depositary Shares
NASDAQ:WYHG
0.026x
111 Inc
NASDAQ:YI
0.139x

Annual Cash Flow Conversion Efficiency for Resverlogix Corp. (2001–2025)

The table below shows the annual cash flow conversion efficiency of Resverlogix Corp. from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see RVX market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$-88.80 Million
≈ $-64.24 Million
CA$-3.73 Million
≈ $-2.69 Million
0.042x -11.77%
2024-12-31 CA$-81.73 Million
≈ $-59.13 Million
CA$-3.89 Million
≈ $-2.81 Million
0.048x +35.51%
2023-12-31 CA$-74.47 Million
≈ $-53.87 Million
CA$-2.61 Million
≈ $-1.89 Million
0.035x -41.26%
2022-12-31 CA$-59.28 Million
≈ $-42.88 Million
CA$-3.54 Million
≈ $-2.56 Million
0.060x -55.43%
2021-12-31 CA$-59.87 Million
≈ $-43.31 Million
CA$-8.02 Million
≈ $-5.80 Million
0.134x +121392.30%
2020-12-31 CA$-39.90 Million
≈ $-28.86 Million
CA$-4.40K
≈ $-3.18K
0.000x -99.96%
2019-12-31 CA$-64.11 Million
≈ $-46.38 Million
CA$-17.34 Million
≈ $-12.55 Million
0.271x +15.07%
2018-12-31 CA$-207.72 Million
≈ $-150.26 Million
CA$-48.83 Million
≈ $-35.33 Million
0.235x -21.73%
2017-12-31 CA$-83.68 Million
≈ $-60.53 Million
CA$-25.13 Million
≈ $-18.18 Million
0.300x +34.58%
2016-12-31 CA$-101.57 Million
≈ $-73.47 Million
CA$-22.67 Million
≈ $-16.40 Million
0.223x -41.21%
2015-12-31 CA$-56.43 Million
≈ $-40.82 Million
CA$-21.42 Million
≈ $-15.50 Million
0.380x +229.32%
2014-12-31 CA$-73.73 Million
≈ $-53.33 Million
CA$-8.50 Million
≈ $-6.15 Million
0.115x -44.80%
2013-12-31 CA$-63.22 Million
≈ $-45.73 Million
CA$-13.20 Million
≈ $-9.55 Million
0.209x -78.75%
2012-12-31 CA$-29.50 Million
≈ $-21.34 Million
CA$-29.00 Million
≈ $-20.98 Million
0.983x +111.21%
2011-12-31 CA$2.74 Million
≈ $1.98 Million
CA$-24.03 Million
≈ $-17.38 Million
-8.766x -95.92%
2010-12-31 CA$4.30 Million
≈ $3.11 Million
CA$-19.24 Million
≈ $-13.92 Million
-4.474x -8.91%
2009-12-31 CA$4.46 Million
≈ $3.23 Million
CA$-18.34 Million
≈ $-13.26 Million
-4.108x -266.55%
2008-12-31 CA$11.61 Million
≈ $8.40 Million
CA$-13.01 Million
≈ $-9.41 Million
-1.121x +68.96%
2007-12-31 CA$5.44 Million
≈ $3.94 Million
CA$-19.65 Million
≈ $-14.21 Million
-3.611x -137.13%
2006-12-31 CA$-1.02 Million
≈ $-738.42K
CA$-9.93 Million
≈ $-7.18 Million
9.724x +1749.37%
2005-12-31 CA$7.48 Million
≈ $5.41 Million
CA$-4.41 Million
≈ $-3.19 Million
-0.590x -166.26%
2004-12-31 CA$9.84 Million
≈ $7.12 Million
CA$-2.18 Million
≈ $-1.58 Million
-0.221x +35.03%
2003-12-31 CA$2.60 Million
≈ $1.88 Million
CA$-885.04K
≈ $-640.23K
-0.341x +29.20%
2002-12-31 CA$942.21K
≈ $681.58K
CA$-453.56K
≈ $-328.10K
-0.481x -1038.52%
2001-12-31 CA$259.64K
≈ $187.82K
CA$-10.98K
≈ $-7.94K
-0.042x --

About Resverlogix Corp.

TO:RVX Canada Biotechnology
Market Cap
$22.93 Million
CA$31.70 Million CAD
Market Cap Rank
#24679 Global
#950 in Canada
Share Price
CA$0.10
Change (1 day)
+0.00%
52-Week Range
CA$0.04 - CA$0.23
All Time High
CA$4.79
About

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor for patients with cardiovascular disease, chronic kidney disease, type 2 diabetes mellitus, low high-density lipoprotein, recent acute coronary syndrome, and post COVID… Read more